Biogen Inc. buy Jefferies Financial Group Inc.
Start price
28.11.25
/
50%
€156.30
Target price
28.11.26
€181.27
Performance (%)
-5.34%
Price
22.01.26
€147.95
Summary
This prediction is currently active. With a performance of -5.34%, the BUY prediction for Biogen Inc. by Jefferies_Financial_ is down slightly. This prediction currently runs until 28.11.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 1.824% | 1.824% |
| iShares Core DAX® | -1.673% | 2.237% |
| iShares Nasdaq 100 | -1.346% | 0.290% |
| iShares Nikkei 225® | -1.529% | 5.863% |
| iShares S&P 500 | -1.702% | 0.697% |
Comments by Jefferies_Financial_ for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its price target raised by analysts at Jefferies Financial Group Inc. from $190.00 to $210.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat